TC
ROIV icon

Truvestments Capital’s Roivant Sciences ROIV Stock Holding History

Truvestments Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
3,788
+108
+3% +$3.19K 0.02% 366
2026
Q1 		$102K Hold
3,680
– – 0.02% 379
2025
Q4 		$79.9K Buy
3,680
+1,925
+110% +$38K 0.01% 375
2025
Q3 		$26.6K Buy
1,755
+281
+19% +$3.48K ﹤0.01% 542
2025
Q2 		$16.6K Buy
+1,474
New +$16K ﹤0.01% 568

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Truvestments Capital's ROIV Position: Q2 2026 in Review

Truvestments Capital increased its Roivant Sciences (ROIV) stake by 2.9% in Q2 2026, buying an estimated $3.19K and bringing the position to 3,788 shares worth $134K. The position accounts for 0.02% of the portfolio, ranked #366.

Truvestments Capital first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Truvestments Capital held 3,788 shares of Roivant Sciences worth $134K as of Q2 2026.
  • Truvestments Capital bought 108 Roivant Sciences shares in Q2 2026, an estimated $3.19K.
  • Roivant Sciences made up 0.02% of Truvestments Capital's portfolio in Q2 2026, its #366 holding.
  • Truvestments Capital first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.